Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial.
Lawal IO, Jani AB, Adediran OA, Goyal S, Abiodun-Ojo OA, Dhere VR, Marcus CV, Joshi SS, Master VA, Patel PR, Goodman M, Shelton JW, Kucuk O, Hershatter B, Fielder B, Halkar RK, Schuster DM. Lawal IO, et al. Among authors: joshi ss. J Nucl Med. 2023 Apr;64(4):586-591. doi: 10.2967/jnumed.122.264832. Epub 2022 Nov 3. J Nucl Med. 2023. PMID: 36328489 Free PMC article.
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy.
Lawal IO, Marcus C, Schuster DM, Goyal S, Adediran OA, Dhere VR, Joshi SS, Abiodun-Ojo OA, Master VA, Patel PR, Fielder B, Goodman M, Shelton JW, Kucuk O, Hershatter B, Halkar RK, Jani AB. Lawal IO, et al. Among authors: joshi ss. Clin Nucl Med. 2023 Apr 1;48(4):e153-e159. doi: 10.1097/RLU.0000000000004590. Epub 2023 Feb 8. Clin Nucl Med. 2023. PMID: 36754362 Free PMC article.
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
Surasi DS, Eiber M, Maurer T, Preston MA, Helfand BT, Josephson D, Tewari AK, Somford DM, Rais-Bahrami S, Koontz BF, Bostrom PJ, Chau A, Davis P, Schuster DM, Chapin BF; LIGHTHOUSE Study Group. Surasi DS, et al. Eur Urol. 2023 Oct;84(4):361-370. doi: 10.1016/j.eururo.2023.06.018. Epub 2023 Jul 5. Eur Urol. 2023. PMID: 37414702 Free article.
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
Schmeusser BN, Biermann H, Nicaise EH, Ali AA, Patil DH, Midenberg E, Helman T, Armas-Phan M, Nabavizadeh R, Joshi SS, Narayan VM, Bilen MA, Psutka SP, Ogan K, Master VA. Schmeusser BN, et al. Among authors: joshi ss. Oncologist. 2023 Dec 11;28(12):e1219-e1229. doi: 10.1093/oncolo/oyad218. Oncologist. 2023. PMID: 37540787 Free PMC article.
Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two Decades.
Hopkins BD, Qian DC, Xu KM, McCook-Veal A, Switchenko J, Hartsell LM, Cimmino CB, Joshi SS, Narayan V, Master VA, Nazha B, Carthon BC, Bilen MA, Kucuk O, Shelton JW, Patel PR, Jani AB, Remick JS, Eng TY. Hopkins BD, et al. Among authors: joshi ss. Clin Genitourin Cancer. 2024 Nov 28;23(1):102276. doi: 10.1016/j.clgc.2024.102276. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39709687 No abstract available.
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches.
Gontero P, Marra G, Alessio P, Filippini C, Oderda M, Munoz F, Linares E, Sanchez-Salas R, Challacombe B, Dasgupta P, Goonewardene S, Popert R, Cahill D, Gillatt D, Persad R, Palou J, Joniau S, Piechaud T, Morlacco A, Vidit S, Rouprêt M, De La Taille A, Albisinni S, Gandaglia G, Mottrie A, Joshi S, Fiscus G, Berger A, Aron M, Van Der Poel H, Tilki D, Lawrentschuk N, Murphy DG, Leung G, Davis J, Karnes RJ; Collaborators. Gontero P, et al. J Urol. 2019 Oct;202(4):725-731. doi: 10.1097/JU.0000000000000327. Epub 2019 Sep 6. J Urol. 2019. PMID: 31075058
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.
Marra G, Karnes RJ, Calleris G, Oderda M, Alessio P, Palazzetti A, Battaglia A, Pisano F, Munegato S, Munoz F, Filippini C, Ricardi U, Linares E, Sanchez-Salas R, Goonewardene S, Dasgupta P, Challacombe B, Popert R, Cahill D, Gillatt D, Persad R, Palou J, Joniau S, Smelzo S, Piechaud T, Taille A, Roupret M, Albisinni S, van Velthoven R, Morlacco A, Vidit S, Gandaglia G, Mottrie A, Smith J, Joshi S, Fiscus G, Berger A, Aron M, Abreu A, Gill IS, Van Der Poel H, Tilki D, Murphy D, Lawrentschuk N, Davis J, Gontero P. Marra G, et al. Urol Oncol. 2021 May;39(5):296.e21-296.e29. doi: 10.1016/j.urolonc.2020.11.002. Epub 2021 Jan 10. Urol Oncol. 2021. PMID: 33436329
Correction: Exploration of bioactive molecules from Sesbania grandiflora (L.): identification of squalene as an effective compound against the two-spotted spider mite, Tetranychus urticae Koch, through molecular docking.
Joshi SSP, Sumathi E, Murugan M, Haran R, Priya SS, Shandeep G, Mohankumar S, Uma D, Nelson A. Joshi SSP, et al. Exp Appl Acarol. 2025 Jan 16;94(2):27. doi: 10.1007/s10493-025-00998-9. Exp Appl Acarol. 2025. PMID: 39820595 No abstract available.
398 results